GSP Neonatal 17α-OH-progesterone kit

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Australia

Austria

Belgium

Brazil *

Canada

China *

Denmark

Finland

France

Germany

Hong Kong *

India *

Ireland

Italy

Japan *

Luxembourg

Mexico *

Netherlands

Norway

Philippines *

Republic of Korea *

Singapore *

Spain

Sweden

Switzerland

Thailand *

United Kingdom

United States

GSP Neonatal 17α-OH-progesterone kit

SDS

Congenital adrenal hyperplasia (CAH) is a genetic disorder and the most severe form of the disease can lead to a life threatening condition during the first weeks of life. The disease is caused by enzyme defects in steroid biosynthesis, the most frequent types being 21- and 11α-hydroxylase deficiency.

Product information

Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.

SDS

Part number: 3305-0010

Product Compatibility: GSP

Request More Information

Product information

Overview

These types represent 95% of CAH cases and in both, the 17α-OH progesterone (17OHP), a precursor of cortisol, is increased. The determination of 17OHP is thus a useful screening method for 95% of all CAH cases.

GSP Neonatal 17α-OH-progesterone assay

The GSP Neonatal 17α-OH-progesterone assay is intended for the quantitative determination of 17OHP in dried blood spot specimens as an aid in screening newborns for CAH.

Incubation time 3 h
Sensitive, robust DELFIA chemistry for confidence in results
Not affected by EDTA, citrate or heparin in samples
All reagents are ready to use
Contains reagents and plates for 1152 tests (12 plates)

Specifications

Other Specifications

Application	Newborn Screening
Assay Technology	DELFIA
Brand	GSP^®
Detection Method	DELFIA
Disorders	Congenital Adrenal Hyperplasia (CAH)
Product Compatibility	GSP
Sample Type	Dried blood spots